>
FSD Pharma Inc logo

HUGE - FSD Pharma Inc Share Price

$1.68 0.1  3.7%

Last Trade - 14/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £41.5m
Enterprise Value £12.6m
Revenue £n/a
Position in Universe 5509th / 6851
Bullish
Bearish
Unlock HUGE Revenue
Momentum
Relative Strength (%)
1m -9.64%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -88.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.089 0.26 0.000 19.8
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2021, FSD PharmaInc revenues was not reported. Net loss beforeextraordinary items decreased 13% to C$9.4M. Lower net lossreflects FV Adjustments of Financial Investments increasefrom C$2.7M (expense) to C$961K (income), General andadministrative decrease of 24% to C$3M (expense),Impairment of right-of-use asset decrease from C$119K(expense) to C$0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

HUGE Revenue Unlock HUGE Revenue

Net Income

HUGE Net Income Unlock HUGE Revenue

Normalised EPS

HUGE Normalised EPS Unlock HUGE Revenue

PE Ratio Range

HUGE PE Ratio Range Unlock HUGE Revenue

Dividend Yield Range

HUGE Dividend Yield Range Unlock HUGE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
HUGE EPS Forecasts Unlock HUGE Revenue
Profile Summary

FSD Pharma Inc is a Canada-based company engaged in the cultivation of cannabis. The Company through its wholly owned subsidiary, FV Pharma, operates as an authorized licensed producer of cannabis for medical purposes (ACMPR). In addition, the Company also owns stakes in Canara, which specializes in indoor cultivation.

Directors
Last Annual December 31st, 2020
Last Interim March 31st, 2021
Incorporated November 1, 1998
Public Since May 29, 2018
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market (Dual Listing)
Shares in Issue 35,991,918
Free Float (0.0%)
Eligible for
ISAs
SIPPs
HUGE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for HUGE
Upcoming Events for HUGE
Frequently Asked Questions for FSD Pharma Inc
What is the FSD Pharma Inc share price?

As of 14/05/21, shares in FSD Pharma Inc are trading at $1.68, giving the company a market capitalisation of £41.5m. This share price information is delayed by 15 minutes.

How has the FSD Pharma Inc share price performed this year?

Shares in FSD Pharma Inc are currently trading at $1.68 and the price has moved by -39.08% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the FSD Pharma Inc price has moved by -57.23% over the past year.

What are the analyst and broker recommendations for FSD Pharma Inc?

There are no analysts currently covering FSD Pharma Inc.

When will FSD Pharma Inc next release its financial results?

FSD Pharma Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the FSD Pharma Inc dividend yield?

FSD Pharma Inc does not currently pay a dividend.

Does FSD Pharma Inc pay a dividend?

FSD Pharma Inc does not currently pay a dividend.

When does FSD Pharma Inc next pay dividends?

FSD Pharma Inc does not currently pay a dividend.

How do I buy FSD Pharma Inc shares?

To buy shares in FSD Pharma Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of FSD Pharma Inc?

Shares in FSD Pharma Inc are currently trading at $1.68, giving the company a market capitalisation of £41.5m.

Where are FSD Pharma Inc shares listed? Where are FSD Pharma Inc shares listed?

Here are the trading details for FSD Pharma Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: HUGE
What kind of share is FSD Pharma Inc?

Based on an overall assessment of its quality, value and momentum, FSD Pharma Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a FSD Pharma Inc share price forecast 2021?

Shares in FSD Pharma Inc are currently priced at $1.68. At that level they are trading at 0.522% discount to the analyst consensus target price of 0.00.

Analysts covering FSD Pharma Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.88 for the next financial year.

How can I tell whether the FSD Pharma Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like FSD Pharma Inc. Over the past six months, the relative strength of its shares against the market has been -4.23%. At the current price of $1.68, shares in FSD Pharma Inc are trading at -24.97% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the FSD Pharma Inc PE Ratio?

We were not able to find PE ratio data for FSD Pharma Inc.

Who are the key directors of FSD Pharma Inc?

FSD Pharma Inc's management team is headed by:

Zeeshan Saeed - PRE
Raza Bokhari - CCH
Gerald Goldberg - IND
Anthony Durkacz - CCH
James Datin - IND
Robert Ciaruffoli - IND
Stephen Buyer - IND
Sandra Lottes - VPR
Shahzad Shah - OTH
Larry Kaiser - DRC
Nathan Coyle - CFO
Who are the major shareholders of FSD Pharma Inc?

Here are the top five shareholders of FSD Pharma Inc based on the size of their shareholding:

Bokhari (Raza) Individual Investor
Percentage owned: 6.75% (2.43m shares)
Saeed (Zeeshan) Individual Investor
Percentage owned: 1.4% (504k shares)
Durkacz (Andrew) Individual Investor
Percentage owned: 1.25% (450k shares)
Davy Global Fund Management Limited Investment Advisor
Percentage owned: 1.21% (436k shares)
Durkacz (Anthony) Individual Investor
Percentage owned: 0.48% (174k shares)
Similar to HUGE
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.